You are here

Home » Content

MULTİPL SKLEROZLU OLGUDA ANESTEZİ UYGULAMASI

Anesthetic management of a patient with multiple sclerosis

Journal Name:

  • Selçuk Tıp Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
Aim: Multiple sclerosis (MS), is characterized by demyelination of different parts of brain and spinal cord and episodic neurologic symptoms. In this case report we aimed to present a patient, and high¬lighting anesthetic management for these patients. Case Report: A 42 year old man who had neu¬rogenic bladder with primer progressive multiple sclerosis undergoing bladder stone operation is discussed. Conclusion: Stress such as surgery or general anesthesia may be associated with an exacerbation of the disease. We thought that to carry out desflurane and remifentanil combination used safely in anesthetic management for MS.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Multiple skleroz (MS), beyin ve spinal kordon farklı bölümlerinin demyelinizasyonu ve epizodik nörolojik semptomlarla karakterize bir hastalıktır. Bu olguda, literatürler yardımıyla anestezik yön¬temimizi anlatmayı amaçladık. Olgu Sunumu: Nörojenik mesanesi olan ve mesane taşı için opere edilen primer progresif multiple sklerozlu 42 yaşındaki erkek hasta tartışıldı. Sonuç: Cerrahi ya da genel anestezi gibi stres durumları hastalığı alevlendirebilmektedir. Bu olgunun anestezisinde uygu¬ladığımız desfluran ve remifentanil kombinasyonunu MS'da güvenle kullanılabileceğini düşünmek¬teyiz.
FULL TEXT (PDF): 
PDF icon arastirmax-multipl-sklerozlu-olguda-anestezi-uygulamasi.pdf
  • 2
95-98
  • Turkish

REFERENCES

References: 

1. Frohman EM. Multiple Sclerosis. Medic Clin North Am 2003; 87(4):867-97
2. Yamashita K, Yokoyama T, Tokai H, Imazu Y, Lee M, Manabe M. Anesthetic management for a patient with multiple sclerosis at exacerbation stage under general anesthesia. Masui 2003; 52(5):521-3
3. Poser CM, Brinar VV. The symptomatic treatment of multiple sclerosis. Clin Neurol Neurosurg 2002; 104(3):231-5
4. Johnson KP. The historical development of interfer¬ons as multiple sclerosis therapies. J Mol Med 1997; 75(2):89-94
5. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographicallybased study I. Clinical course and disability. Brain 1989; 112:133-46
6. Litwiller SE, Frohman EM, Zimmem PE. Multiple Sclerosis and the urologist. J Urol 1999; 161:743-57
7. Betts CD, D'Mellow MT, Fowler JC. Urinary symp¬toms and the neurological features of bladder dys¬function in multiple sclerosis. J Neurol Neurosurg
Psychiatry 1993; 56:245-50
8. Hawker KS, Frohman EM. Bladder, Bowel and sex-uel Dysfunction in Multiple Sclerosis. Curr Treat Options Neurol 2001; 3:207-14
9. Zivadinov R, Iona L, Monti-Bragadin L, Bosco A, Jurjevic A, Taus C, et al. The use of standardized inci-dence and prevalence rates in epidemic logical studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology 2003; 22:65-74

10. Koldewijn EL, Hommes OR, Lemmens WA, Debruyne FM, Van Kerrebroeck PE. Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J Urol 1995;
154:169-73
11. Birder LA, Apadaca G, De Groat WC, Kanai AJ. Adrenergic-and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary blad¬der. Am J Physiol 1998; 275:226-9

12. Andersson KE, Chappie C, Wein A. The basis for drug treatment of the overactive bladder. World J Uroi 2001; 19:294-8
13. Njehalt GJ, Van Walderveen MA, Casteljns JA, Van Waesberghe JH, Polman C, Scheltens P, et al. Brain and Spinal Cord abnormalities in multiple sclero¬sis. Correlation between MRI parameters, clinical sub-types and symptoms. Brain 1998; 121:687-97
14. Kim YH, Goodman C, Omessi E, Rivera V, Kattan MW, Boone TB. The correlation of urodynamic find¬ings with cranial magnetic resonance imaging findings in multiple sclerosis. J Urol 1998; 159:972-6
15. Badder AM, Hunt CO, Datta S, Naulty JS, Ostheimer GW. Anesthesia for the obsthetric patient with multiple sclerosis. J Clin Anesth 1988; 1(1):21-4
16. Kohno K, Uchida H, Yamamoto N, Kosaka Y.
Sevoflurane anesthesia in a patient with multiple scle-
rosis. Masui 1994; 43(8):1229-32
17. Salo M, Pirttikangas CO, Pulkki K. Effects of propo-
fol emulsion and thiopentone on T helper cell type 1 /
type 2 balance in vitro. Anaesthesia 1997; 52:341-4
18. Dorotta RI, Schubert A. Multiple Sclerosis and anesthetic implications. Curr Opin Anaesthesiol 2002;
15:365-70
19. Kytta J, Rosenberg PH. Anesthesia for patients with multiple sclerosis. Ann Chir Gynaecol 1984; 73(5):299-303
20. Martz DG, Schreibman DI, Matjaska MJ.
Anesthesia and uncommon diseases, 3 rd Ed.
Philadelphia, WB Saunders Company 1990; 576-7
21. Davis FA, Michael JA, Neer D. Serial hyperthermia testing in multiple sclerosis: a method for monitoring subclinical fluctuations. Acta Neurol Scand 1973;
49:63-74
22. Glass PS. Remifentanil: A new opioid. J Clin Anesth
1995; 7:558-63
23. Patel SS, Spencer CM. Remifentanil. Drugs 1996; 52(3):417-27

Thank you for copying data from http://www.arastirmax.com